Alembic Pharma announces partner NATCO Pharma gets USFDA tentative nod for Olaparib tablets EP News Bureau Jul 20, 2026 Alembic will distribute the product in the US, and its partner NATCO will manufacture Olaparib Tablets, 100 mg and 150 mg
NATCO announces ANDA filing for generic olaparib tablets in US EP News Bureau Feb 13, 2023 Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic and prostrate cancer
AstraZeneca gets DCGI nod to import and market Olaparib film coated tablets EP News Bureau Aug 19, 2020 It is additionally indicated as a monotherapy to treat adults with metastatic castration-resistant prostate cancer and homologous…
